
- Industry news
Industry news
- Category news
- Reports
- Key trends
- Multimedia
Multimedia
- Journal
- Events
- Suppliers
Suppliers
- Home
- Industry news
Industry news
- Category news
- Reports
- Key trends
- Multimedia
Multimedia
- Events
- Suppliers
Suppliers
Human milk oligosaccharides (HMOs) selectively feed human residential bacteria (HRB). HRB, such as Bifidobacterium longum or B. infantis, can utilize HMOs – setting them apart from animal- or fermented dairy-derived strains. Chyn Boon Wong, lead research associate at Morinaga Milk, explains how a chance discovery kicked off research into HMO utilization and the tryptophan metabolite indole-3-lactic acid, which is produced at high levels when HRB digests HMOs.
Upcoming webinars

The science of HMOs – A novonesis webinar featuring new clinical findings and ESPGHAN highlights
Novonesis

From boosters to companions: GLP-1 in Food, Beverages and Supplements
Rousselot

Top Nutrition Trends 2027
Nutrition Insight














